Medicare spending rises after private equity buys hospices
· Medical Xpressedited by Gaby Clark, reviewed by Andrew Zinin
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add to Preferred Sources
A study of for-profit hospices acquired by private equity firms found that Medicare spending rose by 5.9% per hospice stay after acquisition, compared with similar for-profit hospices that weren't acquired. The increase was driven mainly by longer stays, with the average length of stay rising by 6.3 days. This was likely related to shifts toward patients who use less daily care, including a significant increase in the share of patients with dementia, consistent with a larger share of patients discharged from hospice alive.
Medicare pays hospices a set daily fee regardless of how much care a patient needs. The researchers found no increase in services at private equity–acquired hospices, and instead fewer social work visits. Specifically, there were no increases in physician, nurse or home health visits that may have kept patients alive longer. This suggests the increased length of stay and live discharges may be partly due to a shift toward patients who need less ongoing care, beyond what other for-profit hospices were already doing, the researchers said.
The findings are published in the November issue of Health Affairs.
"The goal of hospice is to provide respectful, person-centered care that helps terminally ill people approach end of life with dignity, while minimizing pain and suffering," said senior author Zirui Song, associate professor of health care policy in the Blavatnik Institute at Harvard Medical School and HMS associate professor of medicine at Massachusetts General Hospital, where he is a general internist.
"For patients and their families, this comes at a stressful time in their lives, and we have a responsibility to make sure the system works well for all of the people who need it and that it is financially sustainable for our aging population."
Nearly half of the people who die in the United States are Medicare beneficiaries who use hospice, and up to a quarter of Medicare spending occurs in the last year of life.
Private equity's growing role in hospice
Over the past two decades, U.S. hospice ownership has shifted from mostly nonprofit to nearly three-quarters for-profit, and private equity firms are now the fastest-growing type of owner. In a typical private equity deal, a firm buys a company with a mix of money from investors and borrowed money. The debt is usually assigned to the company that is purchased, which must then generate revenue to pay it down, plus interest. Firms also have strong incentives to repay investors quickly, which requires additional revenue.
Song's previous work on private equity has shown that private equity ownership in health care has been associated with concerning changes in hospitals and physician practices, including increases in Medicare spending, decreases in physician workforce and increases in adverse health outcomes, including death, likely related to staffing cuts.
For this study, the researchers wanted to see what happens to care and costs when a hospice that was already for-profit is acquired by private equity. Since both kinds of hospices serve the same population under the same payment system and with a profit motive, would there even be any difference?
The researchers used Medicare fee-for-service claims to compare 191 hospices newly acquired by private equity firms between 2018 and 2022 with 1,305 matched control hospices that were for-profit but not owned by private equity firms. The study looked at the two years before and the two years after each acquisition to see what changed, and it compared that to how things changed in the control group.
The research showed there were significant differences. Underlying the increase in spending, patients at hospices acquired by private equity stayed in hospice longer than patients at control hospices. A smaller share had very short stays of less than a week, more stayed longer than six months, and patients were more likely to be discharged from hospice alive.
A shift in which patients were admitted
There was also a change in the mix of patients admitted to hospices after acquisition by private equity. The share of patients with dementia rose from 22.6% to 23.8%, while the share at control hospices did not change.
In the study, the two biggest groups of patients in hospice were people with dementia and people with cancer. Medicare pays the same daily fee for a patient with dementia whose decline is gradual and who needs relatively few services as it pays for a person with cancer who needs frequent visits and complex pain management. The cost of those services and provider visits comes out of the daily fee.
The researchers checked to see if the longer stays and live discharges could be explained by a difference in the care delivered. Did hospices provide more services after private equity acquisition? The answer was no. There was no significant change in total visits or time spent on visits per week, and if anything, the patients received fewer social work visits.
The more likely explanation for the longer stays and live discharges was a shift toward admitting patients who required less care, Song said.
"That makes sense from the point of view of a for-profit facility that looks to generate revenue under this payment system," Song said. "The bigger question is whether that is the best payment model for meeting the needs of people who need hospice, or of ensuring that Medicare spending is sustainable."
The researchers wrote that policy changes to Medicare's hospice payment system may be warranted. One option is adjusting the daily fee by a patient's clinical need. This could be based on patient diagnoses, similar to how hospitals are paid. However, although adjusting for patient risk could reduce the incentive to select lower-risk patients, it could also encourage coding to maximize payment, the authors caution. Other options include separating out fees for needed care, with monitoring to protect against unnecessary use or overbilling of services.
"As the population ages, we should make sure that high-quality hospice care is available for all the patients who need it, as well as sustainable for the Medicare program," Song said.
Publication details
Health Affairs (2026). DOI: 10.1377/hlthaff.2026.00211
Journal information: Health Affairs
Key medical concepts
Clinical categories
Geriatric palliative careHealthy aging Provided by Harvard Medical School Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Medicare spending rises after private equity buys hospices (2026, November 2) retrieved 2 November 2026 from https://medicalxpress.com/news/2026-11-medicare-private-equity-buys-hospices.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.